Skip to content

Illumina Partnerships

Collaborative Partnerships

Sequencing Service Provider Program

The Illumina Propel Certification Program provides your lab with the opportunity to demonstrate competency with select Illumina products through a carefully designed, standardized process. Becoming Propel-Certified also means your lab can gain access to a powerful set of benefits designed to accelerate, differentiate, and propel your lab forward.

Learn More
Accelerator Startup Funding
Accelerator Startup Funding

With mentorship, financial support, and access to sequencers and reagents, we're helping genomics startups launch so we can unlock the power of the genome—together.

Illumina Accelerator Startup Funding

Featured Pharmaceutical & Biotech Partnerships

Some of our existing partnerships include:

Loxo Oncology

Illumina and Loxo Oncology to partner on developing next-generation sequencing-based pan-cancer companion diagnostics.

Read Article
Bristol-Myers Squibb

Bristol-Myers Squibb and Illumina announce strategic collaboration to develop and commercialize companion diagnostics for Bristol-Myers Squibb’s oncology immunotherapies.

Read Article
Merck Serono

Illumina announces strategic collaboration with Merck Serono to expand companion diagnostics for oncology.

Read Article

Press Releases

Discover how Illumina is partnering with others.

Illumina and the Broad Institute Partner to Co-develop Secondary Analysis Tools

llumina and the Broad Institute are partnering to co-develop a suite of secondary genomic analysis pipelines. The partnership will result in new methods, integrating Illumina’s DRAGEN™ Pipelines and technology with Broad’s Genome Analysis Toolkit (GATK).

Read More